Physician profile
J Flint Tomlinson
NPI 1154563294
$2,975.61
in general payments reported to CMS, 2019-2025
6 companies · $7.20 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $492 · 2023: $1,551 · 2024: $209 · 2025: $7.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921 · Entertainment: $500 · Education: $288 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.83 |
| Entertainment | $500.00 |
| Education | $287.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $59.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,462.50 | 2023 | |
| Ivoclar Vivadent, INC. | $715.64 | 2019 | |
| A-Dec, INC. | $380.00 | 2020 | |
| Straumann USA LLC | $263.09 | 2023-2024 | |
| Dentsply LLC | $112.00 | 2020 | |
| Align Technology, INC. | $42.38 | 2023-2025 | Invisalign, Itero Element 5d Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Tomlinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.